Ann: Quarterly Activity Report and Appendix 4C, page-22

https://www.abc.net.au/news/2020-11-06/covid19-vaccine-deals-in-australia-welcome-but-questions-remain/12851750

I hope Andrew and his team are working overtime on the phones with Pfizer and the Australian Government (first and foremost) in marketing our tech as one solution to the myriad of questions concerning the logistics of disseminating the vaccine.

This is honestly the golden opportunity a tech like ours has been waiting for - if we cannot make traction with it right there in our faces then I will have no faith in management and we might as well be bought out by someone that can make something of it.